RheaVita BV

📍 Gent, Belgium🗓 Founded 2018👥 11 employees💰 Last funded Jun 2020
RheaVita invents, develops and sells the technology for continuously freeze drying pharmaceutical products in vials and pre-filled syringes. This innovation is driven by a scientific approach. Therefore strong ties exist between RheaVita and Ghent University and PhD projects are jointly executed. In order to introduce our technology in the pharmaceutical field, our scientific progress is regularly presented in conferences and workshops through organizations such as ISL-FD, PDA and CPPR. The research activities result in numerous publications. Additionally, we execute head-to-head comparison feasibility studies to challenge our technology compared to currently established methods. We have created two prototypes, which are operational and used for the feasibility tests as mentioned above.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2018
Founded
Investor geography2 countries
Belgium
2
Netherlands
1
Investor activity2013–2020 · investors recorded per year
2013120202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in RheaVita BV?
RheaVita BV has 3 investors on record on gritt.io, including 3 early-stage backers.
When did RheaVita BV last raise funding?
The most recent investment in RheaVita BV recorded on gritt.io was in June 2020.
When was RheaVita BV founded?
RheaVita BV was founded in 2018.
What industry is RheaVita BV in?
RheaVita BV operates in Mechanical Or Industrial Engineering. Find similar Mechanical Or Industrial Engineering investors on gritt.io.
Where is RheaVita BV based?
RheaVita BV is headquartered in Gent, Belgium.